Sally C. Pipes
Commentary
Sally Pipes: Democrats’ Drug Pricing Reforms Aren’t What They Seem
As part of their spending bill, Congressional Democrats are advancing legislation that’ll empower Medicare to “negotiate” drug prices in the program’s Part B and Part D benefits. They insist this policy enjoys broad support among voters. But they’re misleading the public. What Democrats are proposing is in fact a sweeping ...
Drug Pricing
NEW BRIEF: Focus Groups Overwhelmingly Disapprove of Government “Negotiated” Drug Pricing
Today, the Pacific Research Institute published an issue brief revealing overwhelming public disapproval for Medicare reforms that Congress is considering as part of its $3.5 trillion spending bill. Click here to read the full issue brief, “Drug Pricing Proposals Threaten America’s Most Vulnerable Patients.” “It’s a relief that Americans oppose ...
Commentary
Democrats Have Built a Healthcare Agenda Around an Imaginary Crisis
Is America in the midst of a health insurance crisis? That’s the picture Democrats in Washington are painting. According to their narrative, health coverage is out of reach for a number of Americans. Only an aggressive — and exorbitantly expensive — effort to expand the number of people covered by taxpayer-funded insurance ...
Commentary
Mixed Messaging On Boosters Leaves Americans Dazed And Confused
The Food and Drug Administration recently revised its emergency use authorization for Pfizer-BioNTech’s COVID-19 vaccine by approving a booster shot for individuals 65 and older, immunocompromised adults, and people with a high risk of exposure to the virus at work. It’s an exciting development for the nearly 80% of vaccinated Americans who want a ...
Commentary
Bernie’s Not-So-Subtle Single-Payer Plot
Senator Bernie Sanders (I.,Vt.), America’s most prominent proponent of government-run health care, is once again leading the charge to move our country to a single-payer system. As chairman of the Senate Budget Committee, Sanders is pushing a $3.5 trillion budget plan that includes expansions of Medicare, Medicaid, and Obamacare. Some ...
Commentary
Democrats’ Misguided Plan to Expand Medicare Doesn’t Add Up
For weeks, congressional Democrats have been pushing to lower Medicare’s eligibility age from 65 to 60 as part of their $3.5 trillion spending bill. A new paper from the American Action Forum (AAF) by Christopher Holt and Stephen Parente reveals just how radical that change would be. Such an expansion of Medicare would cost ...
Commentary
The FDA’s waiting game is costing children’s lives
This week, Pfizer-BioNTech submitted data to the Food and Drug Administration demonstrating the safety and effectiveness of its COVID-19 vaccine in children ages 5 to 11. The duo is expected to apply for emergency-use authorization in the coming weeks. Federal regulators have promised they’ll “urgently” review the data. The FDA’s ...
Commentary
Drug Price Controls Inflict Worse Harm Than Even Critics Recognize
It’s no secret that H.R. 3 — the Democrats’ plan to impose price controls on prescription drugs — would have devastating consequences for our healthcare sector. After all, artificially restricting the price of any product invariably leads to shortages, rationing, and a slowdown in both investment and innovation. A new ...
Commentary
As Democrats Push Single-Payer, Brits Hope To Escape It
A record 5.6 million patients in the United Kingdom are currently on waiting lists for hospital care. That’s equivalent to nearly one in 10 Britons. Of that group, about 300,000 have been waiting at least one year for treatment. Those who can afford to are increasingly paying out of pocket for private care. More than ...
Commentary
Slow FDA approvals of at-home rapid tests have prolonged the pandemic
The delta variant has wreaked havoc. This week, the U.S. reported a seven-day average of more than 146,000 daily cases . In total, COVID-19 has killed more than 660,000 Americans since the start of the pandemic. Thankfully, the rate of increase appears to be falling in many areas, compared to ...
Sally Pipes: Democrats’ Drug Pricing Reforms Aren’t What They Seem
As part of their spending bill, Congressional Democrats are advancing legislation that’ll empower Medicare to “negotiate” drug prices in the program’s Part B and Part D benefits. They insist this policy enjoys broad support among voters. But they’re misleading the public. What Democrats are proposing is in fact a sweeping ...
NEW BRIEF: Focus Groups Overwhelmingly Disapprove of Government “Negotiated” Drug Pricing
Today, the Pacific Research Institute published an issue brief revealing overwhelming public disapproval for Medicare reforms that Congress is considering as part of its $3.5 trillion spending bill. Click here to read the full issue brief, “Drug Pricing Proposals Threaten America’s Most Vulnerable Patients.” “It’s a relief that Americans oppose ...
Democrats Have Built a Healthcare Agenda Around an Imaginary Crisis
Is America in the midst of a health insurance crisis? That’s the picture Democrats in Washington are painting. According to their narrative, health coverage is out of reach for a number of Americans. Only an aggressive — and exorbitantly expensive — effort to expand the number of people covered by taxpayer-funded insurance ...
Mixed Messaging On Boosters Leaves Americans Dazed And Confused
The Food and Drug Administration recently revised its emergency use authorization for Pfizer-BioNTech’s COVID-19 vaccine by approving a booster shot for individuals 65 and older, immunocompromised adults, and people with a high risk of exposure to the virus at work. It’s an exciting development for the nearly 80% of vaccinated Americans who want a ...
Bernie’s Not-So-Subtle Single-Payer Plot
Senator Bernie Sanders (I.,Vt.), America’s most prominent proponent of government-run health care, is once again leading the charge to move our country to a single-payer system. As chairman of the Senate Budget Committee, Sanders is pushing a $3.5 trillion budget plan that includes expansions of Medicare, Medicaid, and Obamacare. Some ...
Democrats’ Misguided Plan to Expand Medicare Doesn’t Add Up
For weeks, congressional Democrats have been pushing to lower Medicare’s eligibility age from 65 to 60 as part of their $3.5 trillion spending bill. A new paper from the American Action Forum (AAF) by Christopher Holt and Stephen Parente reveals just how radical that change would be. Such an expansion of Medicare would cost ...
The FDA’s waiting game is costing children’s lives
This week, Pfizer-BioNTech submitted data to the Food and Drug Administration demonstrating the safety and effectiveness of its COVID-19 vaccine in children ages 5 to 11. The duo is expected to apply for emergency-use authorization in the coming weeks. Federal regulators have promised they’ll “urgently” review the data. The FDA’s ...
Drug Price Controls Inflict Worse Harm Than Even Critics Recognize
It’s no secret that H.R. 3 — the Democrats’ plan to impose price controls on prescription drugs — would have devastating consequences for our healthcare sector. After all, artificially restricting the price of any product invariably leads to shortages, rationing, and a slowdown in both investment and innovation. A new ...
As Democrats Push Single-Payer, Brits Hope To Escape It
A record 5.6 million patients in the United Kingdom are currently on waiting lists for hospital care. That’s equivalent to nearly one in 10 Britons. Of that group, about 300,000 have been waiting at least one year for treatment. Those who can afford to are increasingly paying out of pocket for private care. More than ...
Slow FDA approvals of at-home rapid tests have prolonged the pandemic
The delta variant has wreaked havoc. This week, the U.S. reported a seven-day average of more than 146,000 daily cases . In total, COVID-19 has killed more than 660,000 Americans since the start of the pandemic. Thankfully, the rate of increase appears to be falling in many areas, compared to ...
